TABLE 2.
Clinical conditions and care in ICU.
| N (%) or mean +/− SD | Number of patients with data available (%) | |
|---|---|---|
| SAPS II score | 43.8 +/− 20.3 | 347 (99.1%) |
| Noninvasive ventilation only | 81 (23.1%) | 350 (100%) |
| Intubation and MV | 204 (58%) | 350 (100%) |
| Intubation duration (days) | 12.3 +/− 14.3 | 350 (100%) |
| Intubation within 48 h | 185 (52.9%) | 350 (100%) |
| ARDS | 134 (40.2%) | 333 (95.1%) |
| Vaso‐support drugs within 48 h | 175 (51.5%) | 340 (97.1%) |
| ECMO | 27 (7.7%) | 350 (100%) |
| ECMO duration (days) | 19.1 +/− 24.0 | |
| Dialysis requirement | 64 (19.1%) | 335 (95.7%) |
| Oseltamivir therapy | 229 (66.4%) | 345 (98.6%) |
| H1N1 | 153 (43.7%) | 350 (100%) |
| Vaccination status | 16 (16.6%) | 96 (27.4%) |
| Concomitant bacterial infection | 116 (35.8%) | 324 (92.6%) |
|
Pneumococcus Staphylococcus aureus |
28 (8.6%) 40 (12.3%) |
324 (100%) |
| Leucocytes G/L | 9.399 +/− 6.202 | 347 (99.1%) |
| Hemoglobin g/dL | 12.5 +/− 2.5 | 347 (99.1%) |
| Platelets G/L | 179 +/− 79 | 347 (99.1%) |
| Creatinine μmol/L | 167 +/− 173 | 347 (99.1%) |
| ASAT UI/L | 138 +/− 336 | 333 (95.1%) |
| ALAT UI/L | 83 +/− 232 | 333 (95.1%) |
| CRP mg/L | 155 +/− 141 | 202 (57.7%) |
| Overall mortality | 88 (25.1%) | 350 (100%) |